| P50 | author | Graciela S Alarcón | Q67485107 |
| | John D Reveille | Q67485113 |
| | Jaime Calvo-Alén | Q91866349 |
| | LUMINA Study Group | Q114722503 |
| P2093 | author name string | E B González | |
| | G McGwin | |
| | L M Vilá | |
| | B J Fessler | |
| | M Fernández | |
| | B A Baethge | |
| | H M Bastian | |
| | J M Roseman | |
| | S Toloza | |
| | E J Cepeda | |
| P2860 | cites work | The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 |
| | Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 |
| | Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus | Q33494659 |
| | Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities | Q33561944 |
| | Pathogenesis and natural history of osteonecrosis | Q34995796 |
| | Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment | Q35549979 |
| | Avascular necrosis of bone | Q37974843 |
| | Mechanism of action of antimalarial drugs: inhibition of antigen processing and presentation | Q40709754 |
| | Autoantibodies against oxidized low density lipoproteins (oxLDL): characterization of antibody isotype, subclass, affinity and effect on the macrophage uptake of oxLDL. | Q41291878 |
| | Risk factors of avascular necrosis of the femoral head in patients with systemic lupus erythematosus under high-dose corticosteroid therapy | Q41812170 |
| | Modification of transoperative changes in blood fluidity by hydroxychloroquine: a possible explanation for the drug's antithrombotic effect | Q41919985 |
| | Hydroxychloroquine in prophylaxis of pulmonary embolism following hip arthroplasty | Q41927753 |
| | Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids | Q41943371 |
| | Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group | Q43654524 |
| | Avascular necrosis and its relation to lipid and purine metabolism | Q43732113 |
| | Hyperlipidaemia a risk factor for femoral head osteonecrosis (Legg-Calv -Perthes-like disease) in children with AIDS: case report | Q44080674 |
| | Risk factors for avascular necrosis in systemic lupus erythematosus | Q44577586 |
| | Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus | Q44586795 |
| | Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture | Q46187058 |
| | Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture | Q46430510 |
| | Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies. | Q50196335 |
| | Core decompression for osteonecrosis of the femoral head in systemic lupus erythematosus. | Q50978565 |
| | Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus | Q57740770 |
| | Osteonecrosis after chemotherapy | Q66699238 |
| | Epidemiology of traumatic and nontraumatic osteonecrosis | Q67316560 |
| | Aseptic necrosis of bone in systemic lupus erythematosus. Relationship to corticosteroid therapy | Q67324402 |
| | [Metabolic diseases and idiopathic ischemic necrosis of the femoral head in adults (author's transl)] | Q67336827 |
| | Avascular necrosis of the femoral head with combination therapy | Q67753656 |
| | Osteonecrosis of bone associated with combination chemotherapy without corticosteroids | Q70132882 |
| | Blood lipids in patients with rheumatoid arthritis and avascular necrosis of the femoral head | Q70606473 |
| | Avascular necrosis of bone in neuroblastoma treated with combination chemotherapy | Q70733782 |
| | Ischemic bone necrosis in systemic lupus erythematosus. II. The early diagnosis of ischemic necrosis of bone | Q71146975 |
| | Musculoskeletal complications of systemic lupus erythematosus in the hopkins lupus cohort: An update | Q72009136 |
| | Avascular osteonecrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies | Q72046815 |
| | A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification | Q72293586 |
| | Risk factors for osteonecrosis in systemic lupus erythematosus | Q73218948 |
| | The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus | Q73343774 |
| | Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus | Q73815983 |
| | Association of osteonecrosis in systemic lupus erythematosus with abnormalities of fibrinolysis | Q74284550 |
| | Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture | Q74776728 |
| | Outcomes of symptomatic osteonecrosis in 95 patients with systemic lupus erythematosus | Q74828195 |
| | Risk factors for avascular bone necrosis in systemic lupus erythematosus | Q77291745 |
| | Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus | Q78927175 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| | risk factor | Q1475848 |
| | multiethnicity | Q111242702 |
| P304 | page(s) | 785-790 | |
| P577 | publication date | 2005-11-03 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study | |
| P478 | volume | 65 | |